No Data
No Data
InMed Pharmaceuticals | 10-K: Annual report
InMed Pharmaceuticals Showcases Growth and Drug Advancements
Express News | InMed Pharmaceuticals FY Net Income USD -7.7 Million
InMed Pharmaceuticals Reports Full Year Fiscal 2024 Financial Results and Provides Business Update
InMed Pharmaceuticals Announces Upcoming AGM Date
InMed Pharmaceuticals Faces Nasdaq Delisting Challenge
No Data
No Data